Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours

Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains...

Full description

Saved in:
Bibliographic Details
Published inBMC genomics Vol. 10; no. 1; p. 93
Main Authors Sun, Ruping, Fu, Xuping, Li, Yao, Xie, Yi, Mao, Yumin
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 26.02.2009
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics.
AbstractList Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. Results In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Conclusion Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics.
Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics.
BACKGROUND: Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. RESULTS: In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. CONCLUSION: Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics.
BACKGROUNDRecently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. RESULTSIn this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. CONCLUSIONGlobal gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics.
Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer new possibilities in cancer classification, diagnosis and prognosis. However, the function of miRNAs that are dysregulated in tumours remains largely a mystery. Global analysis of miRNA-target gene expression has helped illuminate the role of miRNAs in developmental gene expression programs, but such an approach has not been reported in cancer transcriptomics. Results In this study, we globally analysed the expression patterns of miRNA target genes in prostate cancer by using several public microarray datasets. Intriguingly, we found that, in contrast to global mRNA transcript levels, putative miRNA targets showed a reduced abundance in prostate tumours relative to benign prostate tissue. Additionally, the down-regulation of these miRNA targets positively correlated with the number of types of miRNA target-sites in the 3' untranslated regions of these targets. Further investigation revealed that the globally low expression was mainly driven by the targets of 36 specific miRNAs that were reported to be up-regulated in prostate cancer by a miRNA expression profiling study. We also found that the transcript levels of miRNA targets were lower in androgen-independent prostate cancer than in androgen-dependent prostate cancer. Moreover, when the global analysis was extended to four other cancers, significant differences in transcript levels between miRNA targets and total mRNA backgrounds were found. Conclusion Global gene expression analysis, along with further investigation, suggests that miRNA targets have a significantly reduced transcript abundance in prostate cancer, when compared with the combined pool of all mRNAs. The abnormal expression pattern of miRNA targets in human cancer could be a common feature of the human cancer transcriptome. Our study may help to shed new light on the functional roles of miRNAs in cancer transcriptomics.
ArticleNumber 93
Audience Academic
Author Sun, Ruping
Fu, Xuping
Li, Yao
Xie, Yi
Mao, Yumin
AuthorAffiliation 1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, PR China
AuthorAffiliation_xml – name: 1 State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, PR China
Author_xml – sequence: 1
  givenname: Ruping
  surname: Sun
  fullname: Sun, Ruping
  email: regularhand@gmail.com
  organization: State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University, Shanghai, PR China. regularhand@gmail.com
– sequence: 2
  givenname: Xuping
  surname: Fu
  fullname: Fu, Xuping
– sequence: 3
  givenname: Yao
  surname: Li
  fullname: Li, Yao
– sequence: 4
  givenname: Yi
  surname: Xie
  fullname: Xie, Yi
– sequence: 5
  givenname: Yumin
  surname: Mao
  fullname: Mao, Yumin
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19245699$$D View this record in MEDLINE/PubMed
BookMark eNp1kt9rnTAUx2V0rD-2572NwGCwB1uPUaMvg9uydRfKBt32HI7xaFM0cYmW9r9f3L10FTp8SDj55KNfzzmODow1FEVvITkFKIszyATEKRRZDElc8RfR0WPl4Mn-MDr2_jZJQJRp_io6hCrN8qKqjqLxsrc19qwjQ4zuR0fea2sYGuwfvPbM0R1hv6zNrKhhWM-mQaOI2ZaN84STviM2aOXs9bcNm9B1NHmmDbuZBzRsdNYHiNg0D3Z2_nX0sg0-erNfT6JfXz7_vPgaX32_3F5sruK6ADHFKufAoU0arHlbCpUKKoB4gipsFE-hhKJosM1yzlMFSiSYI9WQlzyrykrwk2i78zYWb-Xo9IDuQVrU8m_Buk6im7TqSYLgQiihVJBlNRdlhoAJNEhteIUqg-vTzjXO9UCNIjM57FfS9YnRN7KzdzItcp7zRXC-E9Ta_kewPlF2kEv35NI9CYmseJB82H-Fs79n8pMctFfU92jIzl4WIoGkLJfo73dghyGdNq0NTrXAcgNVDgXPSgjU6TNUeBoK3Qxj1upQX134uLoQmInupw5n7-X2x_WaPduxYSy8d9Q-Zg1Zlsl9Jt27p__4H78fVf4HhO3rag
CitedBy_id crossref_primary_10_3892_or_2015_4331
crossref_primary_10_1016_j_bbcan_2014_02_002
crossref_primary_10_12954_PI_12011
crossref_primary_10_1016_j_steroids_2010_11_003
crossref_primary_10_1186_s13148_015_0076_2
crossref_primary_10_1373_clinchem_2013_205450
crossref_primary_10_1373_clinchem_2010_157727
crossref_primary_10_1186_s12865_015_0134_8
crossref_primary_10_1016_j_ando_2014_09_001
crossref_primary_10_1210_me_2011_0099
crossref_primary_10_1186_1475_2867_10_15
crossref_primary_10_3389_fgene_2022_808950
crossref_primary_10_1093_abbs_gmq038
crossref_primary_10_1002_em_20645
crossref_primary_10_1089_dna_2011_1600
crossref_primary_10_3390_ijms140610822
crossref_primary_10_1128_IAI_00649_19
crossref_primary_10_1371_journal_pone_0020271
crossref_primary_10_1074_jbc_M111_335943
crossref_primary_10_1261_rna_1905910
crossref_primary_10_1371_journal_pone_0224071
crossref_primary_10_1093_nar_gkt680
crossref_primary_10_3390_ijms23116281
crossref_primary_10_1007_s11684_009_0055_0
crossref_primary_10_3382_ps_2013_03656
crossref_primary_10_3382_ps_pev289
crossref_primary_10_1039_c0mb00100g
crossref_primary_10_1002_pros_23356
Cites_doi 10.1091/mbc.02-02-0023.
10.1038/35090585
10.1593/neo.07112
10.1073/pnas.0510928103
10.1038/nature06174
10.1002/pros.20756
10.1186/1476-4598-5-24
10.1158/0008-5472.CAN-07-0533
10.1016/S0076-6879(06)11002-2
10.1093/bioinformatics/btl308
10.1200/JCO.2004.05.158
10.1158/0008-5472.CAN-06-4478
10.1016/j.cell.2004.12.038
10.1016/j.cell.2005.11.023
10.1016/j.bbrc.2006.11.080
10.1016/j.ccr.2006.01.013
10.1073/pnas.0304146101
10.1158/0008-5472.CAN-08-0144
10.1038/ng1536
10.1016/j.cell.2005.01.014
10.1038/sj.onc.1210809
10.1016/j.ccr.2005.10.001
10.1261/rna.634607
10.1038/nm733
10.1038/nrc1840
10.1038/msb4100089
10.1038/nature07228
10.1038/sj.leu.2404688
10.1038/nature03702
10.1126/science.1111443
10.1002/ijc.23693
10.1073/pnas.0511045103
10.1126/science.1121158
10.1126/science.1155390
10.1093/nar/gkl1032
10.1007/s00018-007-7054-6
10.1016/j.cell.2004.12.035
10.1073/pnas.0510565103
ContentType Journal Article
Copyright COPYRIGHT 2009 BioMed Central Ltd.
Copyright © 2009 Sun et al; licensee BioMed Central Ltd. 2009 Sun et al; licensee BioMed Central Ltd.
Copyright_xml – notice: COPYRIGHT 2009 BioMed Central Ltd.
– notice: Copyright © 2009 Sun et al; licensee BioMed Central Ltd. 2009 Sun et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ISR
7X8
5PM
DOA
DOI 10.1186/1471-2164-10-93
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Gale in Context: Science
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList
MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1471-2164
EndPage 93
ExternalDocumentID oai_doaj_org_article_17377c7cc4534b3784a1a01daef6dac8
oai_biomedcentral_com_1471_2164_10_93
A195163481
10_1186_1471_2164_10_93
19245699
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
-A0
0R~
23N
2VQ
2WC
2XV
3V.
4.4
53G
5VS
6J9
7X7
88E
8AO
8FE
8FH
8FI
8FJ
AAFWJ
AAHBH
AAJSJ
ABDBF
ABUWG
ACGFO
ACGFS
ACIHN
ACIWK
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
AIXEN
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BBNVY
BCNDV
BENPR
BFQNJ
BHPHI
BMC
BPHCQ
BVXVI
C1A
C24
C6C
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
H13
HCIFZ
HMCUK
HYE
IAO
IGS
IHR
INH
INR
IPNFZ
ISR
ITC
KQ8
LK8
M1P
M48
M7P
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
PSQYO
RBZ
RIG
RNS
ROL
RPM
RSV
SBL
SOJ
SV3
TR2
TUS
U2A
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
CITATION
ABVAZ
AFGXO
AFNRJ
7X8
5PM
ID FETCH-LOGICAL-b617t-c53131f0dab3f87c27e61e30ac7e6c3218166daf45332c1c70a5aeb1583498973
IEDL.DBID RPM
ISSN 1471-2164
IngestDate Tue Oct 22 15:12:54 EDT 2024
Tue Sep 17 21:21:36 EDT 2024
Wed May 22 07:12:46 EDT 2024
Sat Oct 26 01:11:54 EDT 2024
Fri Feb 23 00:21:22 EST 2024
Fri Feb 02 04:38:50 EST 2024
Sat Sep 28 21:00:43 EDT 2024
Thu Sep 12 16:35:04 EDT 2024
Sat Sep 28 07:56:08 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b617t-c53131f0dab3f87c27e61e30ac7e6c3218166daf45332c1c70a5aeb1583498973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653538/
PMID 19245699
PQID 67010887
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_17377c7cc4534b3784a1a01daef6dac8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_2653538
biomedcentral_primary_oai_biomedcentral_com_1471_2164_10_93
proquest_miscellaneous_67010887
gale_infotracmisc_A195163481
gale_infotracacademiconefile_A195163481
gale_incontextgauss_ISR_A195163481
crossref_primary_10_1186_1471_2164_10_93
pubmed_primary_19245699
PublicationCentury 2000
PublicationDate 2009-02-26
PublicationDateYYYYMMDD 2009-02-26
PublicationDate_xml – month: 02
  year: 2009
  text: 2009-02-26
  day: 26
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle BMC genomics
PublicationTitleAlternate BMC Genomics
PublicationYear 2009
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 16286247 - Cancer Cell. 2005 Nov;8(5):393-406
16495412 - Proc Natl Acad Sci U S A. 2006 Mar 14;103(11):4034-9
17141185 - Biochem Biophys Res Commun. 2007 Jan 19;352(3):733-8
17158157 - Nucleic Acids Res. 2007;35(1):152-64
14711987 - Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):811-6
17410184 - Leukemia. 2007 Jun;21(6):1198-203
11518967 - Nature. 2001 Aug 23;412(6849):822-6
16477010 - Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2746-51
15766527 - Cell. 2005 Mar 11;120(5):635-47
17891175 - Oncogene. 2008 Mar 13;27(12):1788-93
18566288 - Science. 2008 Jun 20;320(5883):1643-7
17415519 - Cell Mol Life Sci. 2007 Jul;64(14):1752-62
15766526 - Cell. 2005 Mar 11;120(5):623-34
18366025 - Prostate. 2008 Oct 1;68(14):1496-509
16308420 - Science. 2005 Dec 16;310(5755):1817-21
17237090 - Bioinformatics. 2007 Jan 15;23(2):e184-90
17652130 - RNA. 2007 Sep;13(9):1402-8
12058060 - Mol Biol Cell. 2002 Jun;13(6):1929-39
15944708 - Nature. 2005 Jun 9;435(7043):834-8
16337999 - Cell. 2005 Dec 16;123(6):1133-46
12118244 - Nat Med. 2002 Aug;8(8):816-24
16939783 - Methods Enzymol. 2006;411:14-34
15806104 - Nat Genet. 2005 May;37(5):495-500
16557279 - Nat Rev Cancer. 2006 Apr;6(4):259-69
16784538 - Mol Cancer. 2006;5:24
16969338 - Mol Syst Biol. 2006;2:46
18649363 - Int J Cancer. 2008 Oct 1;123(7):1616-22
15652477 - Cell. 2005 Jan 14;120(1):15-20
17898713 - Nature. 2007 Oct 11;449(7163):682-8
16141059 - Science. 2005 Sep 2;309(5740):1514-8
18676839 - Cancer Res. 2008 Aug 1;68(15):6162-70
17616669 - Cancer Res. 2007 Jul 1;67(13):6130-5
15254046 - J Clin Oncol. 2004 Jul 15;22(14):2790-9
16461460 - Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61
17575136 - Cancer Res. 2007 Jun 15;67(12):5699-707
18668040 - Nature. 2008 Sep 4;455(7209):58-63
16473279 - Cancer Cell. 2006 Feb;9(2):121-32
17356713 - Neoplasia. 2007 Feb;9(2):166-80
M Selbach (1977_CR14) 2008; 455
SM Dhanasekaran (1977_CR17) 2001; 412
MD Mattie (1977_CR6) 2006; 5
R Sandberg (1977_CR23) 2008; 320
1977_CR39
1977_CR37
P Sood (1977_CR13) 2006; 103
YP Yu (1977_CR15) 2004; 22
KP Porkka (1977_CR7) 2007; 67
Z Yu (1977_CR22) 2007; 35
X Chen (1977_CR36) 2002; 13
SM Johnson (1977_CR10) 2005; 120
AL Richardson (1977_CR33) 2006; 9
Q Jing (1977_CR27) 2005; 120
W Li (1977_CR30) 2008; 123
S Varambally (1977_CR18) 2005; 8
Q Cui (1977_CR26) 2006; 2
DR Rhodes (1977_CR38) 2007; 9
DG Beer (1977_CR34) 2002; 8
L Wu (1977_CR1) 2006; 103
M Ozen (1977_CR8) 2008; 27
1977_CR42
1977_CR41
1977_CR40
J Lapointe (1977_CR16) 2004; 101
Q Cui (1977_CR25) 2007; 352
E Wang (1977_CR32) 2007; 64
BP Lewis (1977_CR2) 2005; 120
TS Davison (1977_CR31) 2006; 411
A Andersson (1977_CR35) 2007; 21
S Ambs (1977_CR19) 2008; 68
A Krek (1977_CR9) 2005; 37
S Landais (1977_CR28) 2007; 67
KK Farh (1977_CR11) 2005; 310
A Esquela-Kerscher (1977_CR3) 2006; 6
MJ Moore (1977_CR20) 2005; 309
O Rokhlenko (1977_CR43) 2007; 23
A Stark (1977_CR12) 2005; 123
J Lu (1977_CR5) 2005; 435
H Liang (1977_CR24) 2007; 13
L Ma (1977_CR29) 2007; 449
S Volinia (1977_CR4) 2006; 103
M Jiang (1977_CR21) 2008; 68
References_xml – volume: 13
  start-page: 1929
  issue: 6
  year: 2002
  ident: 1977_CR36
  publication-title: Mol Biol Cell
  doi: 10.1091/mbc.02-02-0023.
  contributor:
    fullname: X Chen
– volume: 412
  start-page: 822
  issue: 6849
  year: 2001
  ident: 1977_CR17
  publication-title: Nature
  doi: 10.1038/35090585
  contributor:
    fullname: SM Dhanasekaran
– volume: 9
  start-page: 166
  issue: 2
  year: 2007
  ident: 1977_CR38
  publication-title: Neoplasia
  doi: 10.1593/neo.07112
  contributor:
    fullname: DR Rhodes
– volume: 103
  start-page: 4034
  issue: 11
  year: 2006
  ident: 1977_CR1
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0510928103
  contributor:
    fullname: L Wu
– volume: 449
  start-page: 682
  issue: 7163
  year: 2007
  ident: 1977_CR29
  publication-title: Nature
  doi: 10.1038/nature06174
  contributor:
    fullname: L Ma
– volume: 68
  start-page: 1496
  issue: 14
  year: 2008
  ident: 1977_CR21
  publication-title: Prostate
  doi: 10.1002/pros.20756
  contributor:
    fullname: M Jiang
– volume: 5
  start-page: 24
  year: 2006
  ident: 1977_CR6
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-5-24
  contributor:
    fullname: MD Mattie
– volume: 67
  start-page: 6130
  issue: 13
  year: 2007
  ident: 1977_CR7
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-07-0533
  contributor:
    fullname: KP Porkka
– ident: 1977_CR41
– volume: 411
  start-page: 14
  year: 2006
  ident: 1977_CR31
  publication-title: Methods Enzymol
  doi: 10.1016/S0076-6879(06)11002-2
  contributor:
    fullname: TS Davison
– volume: 23
  start-page: e184
  issue: 2
  year: 2007
  ident: 1977_CR43
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btl308
  contributor:
    fullname: O Rokhlenko
– volume: 22
  start-page: 2790
  issue: 14
  year: 2004
  ident: 1977_CR15
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.05.158
  contributor:
    fullname: YP Yu
– volume: 67
  start-page: 5699
  issue: 12
  year: 2007
  ident: 1977_CR28
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-4478
  contributor:
    fullname: S Landais
– volume: 120
  start-page: 623
  issue: 5
  year: 2005
  ident: 1977_CR27
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.038
  contributor:
    fullname: Q Jing
– ident: 1977_CR37
– volume: 123
  start-page: 1133
  issue: 6
  year: 2005
  ident: 1977_CR12
  publication-title: Cell
  doi: 10.1016/j.cell.2005.11.023
  contributor:
    fullname: A Stark
– volume: 352
  start-page: 733
  issue: 3
  year: 2007
  ident: 1977_CR25
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.11.080
  contributor:
    fullname: Q Cui
– volume: 9
  start-page: 121
  issue: 2
  year: 2006
  ident: 1977_CR33
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2006.01.013
  contributor:
    fullname: AL Richardson
– volume: 101
  start-page: 811
  issue: 3
  year: 2004
  ident: 1977_CR16
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0304146101
  contributor:
    fullname: J Lapointe
– volume: 68
  start-page: 6162
  issue: 15
  year: 2008
  ident: 1977_CR19
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-08-0144
  contributor:
    fullname: S Ambs
– volume: 37
  start-page: 495
  issue: 5
  year: 2005
  ident: 1977_CR9
  publication-title: Nat Genet
  doi: 10.1038/ng1536
  contributor:
    fullname: A Krek
– ident: 1977_CR39
– volume: 120
  start-page: 635
  issue: 5
  year: 2005
  ident: 1977_CR10
  publication-title: Cell
  doi: 10.1016/j.cell.2005.01.014
  contributor:
    fullname: SM Johnson
– volume: 27
  start-page: 1788
  issue: 12
  year: 2008
  ident: 1977_CR8
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1210809
  contributor:
    fullname: M Ozen
– volume: 8
  start-page: 393
  issue: 5
  year: 2005
  ident: 1977_CR18
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2005.10.001
  contributor:
    fullname: S Varambally
– volume: 13
  start-page: 1402
  issue: 9
  year: 2007
  ident: 1977_CR24
  publication-title: Rna
  doi: 10.1261/rna.634607
  contributor:
    fullname: H Liang
– volume: 8
  start-page: 816
  issue: 8
  year: 2002
  ident: 1977_CR34
  publication-title: Nat Med
  doi: 10.1038/nm733
  contributor:
    fullname: DG Beer
– volume: 6
  start-page: 259
  issue: 4
  year: 2006
  ident: 1977_CR3
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc1840
  contributor:
    fullname: A Esquela-Kerscher
– volume: 2
  start-page: 46
  year: 2006
  ident: 1977_CR26
  publication-title: Mol Syst Biol
  doi: 10.1038/msb4100089
  contributor:
    fullname: Q Cui
– volume: 455
  start-page: 58
  issue: 7209
  year: 2008
  ident: 1977_CR14
  publication-title: Nature
  doi: 10.1038/nature07228
  contributor:
    fullname: M Selbach
– volume: 21
  start-page: 1198
  issue: 6
  year: 2007
  ident: 1977_CR35
  publication-title: Leukemia
  doi: 10.1038/sj.leu.2404688
  contributor:
    fullname: A Andersson
– volume: 435
  start-page: 834
  issue: 7043
  year: 2005
  ident: 1977_CR5
  publication-title: Nature
  doi: 10.1038/nature03702
  contributor:
    fullname: J Lu
– volume: 309
  start-page: 1514
  issue: 5740
  year: 2005
  ident: 1977_CR20
  publication-title: Science
  doi: 10.1126/science.1111443
  contributor:
    fullname: MJ Moore
– volume: 123
  start-page: 1616
  issue: 7
  year: 2008
  ident: 1977_CR30
  publication-title: Int J Cancer
  doi: 10.1002/ijc.23693
  contributor:
    fullname: W Li
– ident: 1977_CR40
– ident: 1977_CR42
– volume: 103
  start-page: 2746
  issue: 8
  year: 2006
  ident: 1977_CR13
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0511045103
  contributor:
    fullname: P Sood
– volume: 310
  start-page: 1817
  issue: 5755
  year: 2005
  ident: 1977_CR11
  publication-title: Science
  doi: 10.1126/science.1121158
  contributor:
    fullname: KK Farh
– volume: 320
  start-page: 1643
  issue: 5883
  year: 2008
  ident: 1977_CR23
  publication-title: Science
  doi: 10.1126/science.1155390
  contributor:
    fullname: R Sandberg
– volume: 35
  start-page: 152
  issue: 1
  year: 2007
  ident: 1977_CR22
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkl1032
  contributor:
    fullname: Z Yu
– volume: 64
  start-page: 1752
  issue: 14
  year: 2007
  ident: 1977_CR32
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-007-7054-6
  contributor:
    fullname: E Wang
– volume: 120
  start-page: 15
  issue: 1
  year: 2005
  ident: 1977_CR2
  publication-title: Cell
  doi: 10.1016/j.cell.2004.12.035
  contributor:
    fullname: BP Lewis
– volume: 103
  start-page: 2257
  issue: 7
  year: 2006
  ident: 1977_CR4
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0510565103
  contributor:
    fullname: S Volinia
SSID ssj0017825
Score 2.141252
Snippet Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling analyses offer...
Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA...
BACKGROUNDRecently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling...
BACKGROUND: Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA profiling...
Abstract Background Recently, microRNAs (miRNAs) have taken centre stage in the field of human molecular oncology. Several studies have shown that miRNA...
SourceID doaj
pubmedcentral
biomedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 93
SubjectTerms 3' Untranslated Regions - genetics
Androgens - metabolism
DNA microarrays
Down-Regulation
Gene expression
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Genetic aspects
Humans
Male
MicroRNAs - genetics
Oligonucleotide Array Sequence Analysis
Physiological aspects
Prostate cancer
Prostatic Neoplasms - genetics
RNA
RNA, Messenger - genetics
Up-Regulation
SummonAdditionalLinks – databaseName: BioMed Central
  dbid: RBZ
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagCIlLVd6hLVgICS4RcezYjnraIqqCRA8LlSouluMHVKLZVZNI8O-ZSdKHW26cdrWejex887I885mQN1E3OkoRch15kwvsAbbaizwKZyumCluNjcJfjuThsfh8Up1ckUXfOMFnWr5n4D7zErJ69Bg1v0vu4XXJaIPL_e-XBwYQ6KqxkWgWnll8_vGAG53tv5KANPL23_bO18JTWjp5LRYdbJHNOYmkiwn1h-ROaB-R-9O1kn8ek_VE5E9BNwINv-dS15bamYCEIm0TqB18ekDWU9tgPwjAT1eRrod-JAOnZ1irtzxa0KlavKOnLR2v9KNrbBWBJJX2wxnMpXtCjg8-fvtwmM83K-QNZCx97sDyOIuFtw2PWrlSBckCL6yDL45j2JfS2yggGSwdc4iZBa9eaS5qXSv-lGy0qzY8J5RFW0tXehEh0MXgawdJJLfKyyJE2O1lZC953WY9sWgY5LVOR8DEDIJlECwDu5OaZ-TdBTiXfxy3LVreFt1H8JLnjz-AMpnZDA1TXCmnnIOViYYrLSyzBfMW5uqt0xl5jdAbZMZosfTmhx26znz6ujQLBlonsW85I29nobiCiTs7dzLAC0EyrURyJ5EE03XJ8KsLDTM4hPVubVgNnZEK9sng_zPybNK3q9XXeFRd1xlRiSYm605H2tOfI294KSsO8e3FfyGyTR5MB2plXsodstGfD2EX8rK-eTla5F88sDWG
  priority: 500
  providerName: BioMedCentral
– databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yIHgR18_qqkEEvZRtmjQfeHqKyyq4h9WFvYU0TXTB7XvYFtb_3pmmb31hD148tTRpaWZ-ycyQmV8IeR11q6MUodSRt6XAGmCnO1FG4V3DVOWauVD4y4k8PhOfz5vznaO-MCcs0QMnwR0yxZXyynvRcNFypYVjrmKdC1F2zqcy38psg6ll_wDsXjPXFSlW1hARLKQ-TMvD62e4AuF-c1bo_jOzTzON_83Fesda5ZmUO6bp6B65u_iUdJXGsk9uhf4-uZ1Omfz9gGwSrz8FqAQarpbM1566hY-EIosToBCuHSi6o67F8hBAA11HupnGmRucXmLq3unJiqbk8YFe9HQ-4Y9usHIEfFY6TpfwL8NDcnb08duH43I5aKFswYEZSw8TkbNYda7lUStfqyBZ4JXzcOM5egEShB1BBbz2zKMKHSzyjebCaKP4I7LXr_vwhFAWnZG-7kQEuxdDZzz4lNypTlagsIoV5F0mbrtJpBoWaa7zFphxFpVlUVkWghXDC_J2q5zrF-coRsubXd-j8rLvzw8AXHYBl_0XuAryClVvkSijx0yc724aBvvp66ldMfBNJZYxF-TN0imu4ce9WwobQCDIrZX1PMh6wkz2WfPLLcIsNmH6Wx_W02ClgrAZzEFBHie8_R29wZ1rYwqiMiRm485b-osfM414LRsO5u7p_xDUM3InbbPVZS0PyN74awrPwVsb2xfzxPwDHJ09uQ
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9UwFA86EXwRv61ODSLoS7Vt0iRFRK7imIJ7mF7YW0jTZA629nrbwvbfe06beRe3B596aXJLcj5yziHn_A4hr7yqlRfcpcqzOuVYA2xUw1PPrSlzmZlyKhT-vid2l_zbQXmwaQcUCNhfGdphP6nl-vjt6e-zj6DwHyaFV-JdDgdsWoDfj2dKxa6TGwWicmEeH99cKYApLKdSozA54Pxc8YF_at-PI5M1IftfPr8vGLA4ufKCtdq5Q24HN5MuZrm4S6659h65OTeePLtPVjPUPwXpcdSdhmTYlpoAUUIR2AkIBM8GeN9QU2PFCAgI7TxdjcMEF05PMJtvf29B53zynh61dGr6R1dYTAJuLB3GE1hL_4Asd778_Lybht4LaQ0-zZBa0E2W-6wxNfNK2kI6kTuWGQs_LEPHQIjGeA7uYmFzi1w1cO6XivFKVZI9JFtt17rHhObeVMIWDfdgCr1rKgtuJjOyEZnzEA8m5H1Ebr2acTY0Il_HI6CEGpmlkVka4peKJeTNOXP-_nEKbJS4PPUTMi_6_vSiWx_qoKg6l0xKK62FnfGaScVNbrK8MbDWxliVkJfIeo3YGS0m5xyase_11x_7epGDuyqwsjkhr8Mk38HCrQm1DkAQhNuKZm5HM0G5bTT84lzCNA5hRlzrurHXQkIkDRYiIY9medvsvsLL7KpKiIwkMdp3PNIe_ZqQxQtRMrCAT_6fpk_Jrfl-rUgLsU22hvXonoGbNtTPJ_X7A0JAOgs
  priority: 102
  providerName: Scholars Portal
Title Global gene expression analysis reveals reduced abundance of putative microRNA targets in human prostate tumours
URI https://www.ncbi.nlm.nih.gov/pubmed/19245699
https://search.proquest.com/docview/67010887
http://dx.doi.org/10.1186/1471-2164-10-93
https://pubmed.ncbi.nlm.nih.gov/PMC2653538
https://doaj.org/article/17377c7cc4534b3784a1a01daef6dac8
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fa9swEBZtx2Avo_tZr10mxmB7cRNZsiSzp6S0dIOEkq0Q9iJkWeoCjROaBLb_fidZ2Sr6thcnRLKRfN_p7qK7Twh9cLKWjjObS0frnPkaYC0bljtmdEnEQJehUHg84ZfX7OusnO2hclcLE5L2TT0_bW8Xp-38Z8itXC1Mf5cn1r8anxW8pKCo_X20DwDdhehx6wBMXhk5fIjkfQKrb15AUOAXnCocm1P5zT5P9pqUuN8mlikQ-D9cpu_ZqTSH8p5RujhET6M3iYfdqJ-hPds-R4-78yV_v0CrjtEfA0gstr9izmuLdWQiwZ6_CfAHnw2IuMG69oUhgAO8dHi13QRWcLzwSXvTyRB3aeNrPG9xONsPr3zNCHireLNdwFjWL9H1xfn3s8s8HrGQ1-C6bHIDKkiJGzS6pk4KUwjLiaUDbeCLod7-c95ox8ArLAwxXngalvdSUlbJStBX6KBdtvYIYeJ0xU3RMAcWz9mmMuBNUi0aPrAOwr4MfU5et1p1dBrKE1ynLaBrystNebkpCFMqmqFPO-H8vTHEL5I_7DrywkueH35Y3t2oCCNFBBXCCGNgZqymQjJN9IA0GsbaaCMz9N6LXnmKjNbn4Nzo7XqtvnybqiEBr5T7AuYMfYyd3BIGbnQsaYAX4lm1kp4nSU_QYZM0v9shTPkmn_jW2uV2rbiAgBkMQYZed3j7N_sI4wyJBInJvNMW0KdAIB71581_33mMnnS7akVe8BN0sLnb2rfgnG3qHqjkTPTQo9H55GraC39xwHXMJFynox-9oKx_AAY_QVY
link.rule.ids 108,230,315,730,783,787,867,888,2109,2228,24332,24951,27938,27939,31734,33759,53806,53808,76148,76149
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfGEIIXvj8Cg1kICV7SxnFiO-KpTEwdrBUaG9qb5Tj2qFjTak0k4K_nnDgwsyd4StVzKl_9O9-dfPczQq-sKIVlmYmFpWWcuR5gJaostplWOeGJyrtG4dmcTU-yD6f56RbKh16Yrmhfl4tRfb4c1YuvXW3leqnHQ53Y-NNsL2U5BUMdX0PX4ZGwIUn3hwfg9HLP4kMEGxPYf-MU0gK35RTdxTmFO-5zdK9Bk_t54Js6Cv-rG_UlTxVWUV5yS_t30JdBob4a5duobcqR_vkX1-M_a3wX3faBKp704ntoy9T30Y3-6sofD9C6vywAA_4MNt99OW2NlSc5wY4aCqANzwrQU2FVup4TgBheWbxum45wHC9dPeDRfIL7ivQNXtS4uzYQr107CgTCuGmXMJfNQ3Sy__54bxr72xviEqKiJtZg3ZTYpFIltYLrlBtGDE2Uhg-autCCsUrZDALOVBPtcKHAc-SCZoUoOH2EtutVbZ4gTKwqmE6rzIIztaYqNASqVPGKJcZCRhmht8E6ynXP1CEdd3YoATOWDhDSAUJCBlTQCL0ZVv33i11qJNjVoe8cKoLf775YXZxJv16ScMq55lqDZllJucgUUQmpFMy1UlpE6KXDlHTsG7Ur7zlT7WYjDz4fyQmBgJe53ugIvfaD7AomrpXvloA_xBF2BSN3gpGwPehAvDtAVzqRq6mrzardSMYhFwcfE6HHPZD_aO_tI0I8gHigdygB4Hbc5B6oT__7zV10c3o8O5SHB_OPz9Ct_vAujUm-g7abi9Y8hxiwKV90Fv8LQGNd7Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdgCMQL3x-BwSyEBC9pkzixHfFUBtUGrJoGk6a9WI5jj4o1jdZEAv56zo4LNXvbU6P6Uvnqn3138t3vEHpteMUNzXXMDani3NYAS17nscmVLFKWyMIVCh_M6N5x_umkONlo9eWS9lU1HzXni1Ez_-5yK9uFGq_zxMaHB7sZLQhs1HFbm_F1dAMeE74O1P0FAhi-wjP5pJyOUziD4wxCA3vslK55Tmmv_Czla1Dofh7YJ0fjf_mw3rBWYSblhmma3kWna6WGjJQfo76rRur3f3yPV9L6HrrjHVY8GUTuo2u6eYBuDi0sfz1E7dA0AAMONdY_fVptg6UnO8GWIgogDp81oKjGsrK1JwA1vDS47TtHPI4XNi_waDbBQ2b6Cs8b7NoH4taWpYBDjLt-AXNZPULH04_fdvdi38UhrsA76mIFu5ykJqllRQxnKmOappokUsGDItbFoLSWJgfHM1OpsviQYEEKTvKSl4w8RlvNstFPEU6NLKnK6tyAUTW6LhU4rESymibaQGQZoXfBWop2YOwQlkM7HIHtLCwohAWFgEioJBF6u175vy-6EInTy6LvLTKC33dfLC_OhF8zkTLCmGJKgWZ5RRjPZSqTtJYw11oqHqFXFlfCsnA0Ns3nTParldj_eiQmKTi-1NZIR-iNFzJLmLiSvmoC_hBL3BVIbgeScEyoYHhnDV9hh2xuXaOX_UpQBjE52JoIPRnA_E97v0cixAKYB3qHIwBex1Huwfrsym_uoFuHH6biy_7s83N0e7jDy-KMbqOt7qLXL8AV7KqXbtP_AQMEYG8
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+gene+expression+analysis+reveals+reduced+abundance+of+putative+microRNA+targets+in+human+prostate+tumours&rft.jtitle=BMC+genomics&rft.au=Sun%2C+Ruping&rft.au=Fu%2C+Xuping&rft.au=Li%2C+Yao&rft.au=Xie%2C+Yi&rft.date=2009-02-26&rft.issn=1471-2164&rft.eissn=1471-2164&rft.volume=10&rft.issue=1&rft_id=info:doi/10.1186%2F1471-2164-10-93&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_1471_2164_10_93
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2164&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2164&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2164&client=summon